| |
What
is MICARDIS (telmisartan)
MICARDIS (telmisartan) is an anti-hypentensive medication,
belonging to the class of angiotensin II receptor blockers (ARBs).
It is effective and well tolerated, providing powerful 24-hour
blood pressure reductors with a once-daily dose.
MICARDIS is widely approved for the treatment
of hypentension. MICARDIS is also available
in two fixed-dosed combinations with 12.5mg thiazide diuretic,
hydrochlorothiade (HCTZ).
Protection against cardiovascular events
MICARDIS is the only ARB shown to provides
and vascular protection beyond the effect of blood pressure
lowering in a broad range of high-risk of cardiodvascular death,
heart attack, stroke and hospitalisation for congestive heart
failure.
Safety and Toleratability
:: Clinical trials have shown MICARDIS to be
as well tolerate as placedo, and an evaluation of safety in
studies involving over 30,000 patients confirms this
:: The excellent toleratibility ptofile of MICARDIS
is supported
by its proven safety and efficacy in high risk patients such
as the elderly and those with varying degrees of renal
impairment, whether mild/moderate, severe or requiring haemodialysis.
:: The tolerability profile of MICARDIS is
also particularly
beneficial to young patients who may require treatment with
an anti-hypertensive for many years.
|
|
|
|